http://www.catalystpharma.com
Catalyst Pharmaceuticals, Inc. Company Intro
Our company is committed to developing novel, safe, and efficacious therapies to improve the lives of people with rare diseases.
Industry
Healthcare
Catalyst Pharmaceuticals, Inc. Headquaters
355 Alhambra Circle
Coral Gables,33134
United States
Catalyst Pharmaceuticals, Inc. Share price
19 Oct 2020 01:24 GMT
$3.2100
0.02 (0.63 %)
Catalyst Pharmaceuticals, Inc. Market cap
$351.093 M
WMC RANKING
2020
Catalyst Pharmaceuticals, Inc. # 48
BiotechnologyLatest Catalyst Pharmaceuticals, Inc. News
19 Oct 2020
Catalyst Pharmaceuticals Announces Filing of Patent ...
(Catalyst) ( CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare ...
19 Oct 2020
Is Now the Time to Invest in EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT)?
The catalyst for this interesting swing was the company's recent earnings report. A Notable Earnings Report. In the last quarter, EYPT reported a profit of $3.62 ...
19 Oct 2020
Which One Is A Better Investment: The Progressive Corporation (PGR) or Catalyst Pharmaceuticals Inc. (CPRX)?
Catalyst Pharmaceuticals Inc. (CPRX) shares on Friday's trading session, jumped 2.51 percent to see the stock exchange hands at $3.27 per unit. Lets a quick ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Catalyst Pharmaceuticals, Inc. | 2.16 | 0.98 | 3.19 | 0 | 0 | 0 | 3.05 |
| Alexion Pharmaceuticals, Inc. | 100 | 11.32 | 100 | 20 | 0 | 0 | 96.20 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 3.68 | 33 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 0 | 0 | 0 | 0.06 |
| Incyte Corporation | 40.27 | 8.70 | 7.11 | 100 | 0 | 0 | 84.84 |
Catalyst Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Catalyst Pharmaceuticals, Inc. | $119,761 | $59,851 | $41,766 | $351.093M | 48 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $27.206B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $56.803B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥20.207B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.821B | 4 |